483
Magnolia Medical Technologies, Inc.Magnolia Medical Technologies, Inc. – FDA 483, Jul 15, 2021
Record Details
Magnolia Medical Technologies, Inc. in Seattle, WA, was inspected and cited for significant deficiencies across its quality system. The inspection revealed inadequate procedures for corrective and preventive actions, design changes, design verification, and production processes. Additionally, the firm failed to adequately investigate device complaints, indicating a systemic breakdown in quality management for its Steripath Gen2 devices.
View Company Profile
ID · db719db6-1526-4781-a02c-41f541833d91
Other documents for Magnolia Medical Technologies, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.